Fridhammar Adam

Adam’s expertise in health economic analysis spans over more than ten years, during which he has published close to twenty academic articles in medical and economical journals. His research primarily focuses on decision analytic modelling, evaluation of medical technologies, and cost-of-illness studies. Adam has acquired a broad range of experience across diverse disease areas, including oncology, diabetes, and obesity.

Education: Master of Science in Health Economics, Lund University